Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Liver Int. 2019 Jul;39(7):1363-1371. doi: 10.1111/liv.14092. Epub 2019 Mar 26.
BACKGROUND & AIMS: Cardiovascular complications are major contributors to mortality at liver transplantation (LT). However, the impact of coronary artery disease (CAD) on these complications is not well-understood as the literature is limited by non-invasive assessment of CAD, which is suboptimal in patients with cirrhosis. Thus, the current study evaluated cardiovascular events at LT stratified according to the presence and severity of CAD quantified on coronary angiography.
All patients who had LT from January 2010 to January 2017 were evaluated (N = 348), but analysis was restricted to patients who had coronary angiography prior to LT (N = 283). Protocol coronary angiography was performed in all patients' ages >50 years, history of CAD, abnormal cardiac stress test or risk factors for CAD. The primary outcome was a cardiovascular composite outcome including myocardial infraction (MI), cardiac arrest, stroke, cardiac death, heart failure or arrhythmia occurring within 4 weeks after LT.
CAD was present in 92(32.5%) patients and 32(11.3%) had obstructive CAD. During the study period, 72(25.4%) patients met the primary cardiovascular outcome, the most common being arrhythmia (N = 59 or 20.8%). Non-ST elevation MI occurred in 11(3.9%) of patients. A total of 10 deaths (3.5%) occurred, of which 6(2.1%) were attributable to cardiac death. There was no evidence of a relationship between the presence and severity of CAD and composite cardiovascular events. In multiple regression modelling, only diabetes [OR 2.62, 95%CI (1.49, 4.64), P < 0.001] was associated with the likelihood of having a cardiovascular event.
Cardiovascular disease mortality is the most important contributor of early mortality after LT but is not related to the severity of CAD.
心血管并发症是肝移植(LT)患者死亡的主要原因。然而,由于文献受到非侵入性 CAD 评估的限制,并且这种方法在肝硬化患者中效果不佳,因此 CAD 对这些并发症的影响仍不明确。因此,本研究根据冠状动脉造影定量评估的 CAD 存在和严重程度,对 LT 后的心血管事件进行分层评估。
评估了 2010 年 1 月至 2017 年 1 月期间所有接受 LT 的患者(N=348),但分析仅限于接受 LT 前进行冠状动脉造影的患者(N=283)。所有年龄>50 岁的患者、有 CAD 病史、异常心脏应激试验或 CAD 危险因素的患者均进行标准冠状动脉造影。主要结局是 LT 后 4 周内发生的心血管复合结局,包括心肌梗死(MI)、心脏骤停、中风、心脏性死亡、心力衰竭或心律失常。
92 例(32.5%)患者存在 CAD,32 例(11.3%)存在阻塞性 CAD。研究期间,72 例(25.4%)患者出现主要心血管结局,最常见的是心律失常(N=59 或 20.8%)。11 例(3.9%)患者发生非 ST 段抬高型 MI。共有 10 例死亡(3.5%),其中 6 例(2.1%)归因于心脏性死亡。CAD 的存在和严重程度与复合心血管事件之间没有证据表明存在关系。在多变量回归模型中,只有糖尿病[比值比 2.62,95%可信区间(1.49,4.64),P<0.001]与发生心血管事件的可能性相关。
心血管疾病死亡率是 LT 后早期死亡的最重要原因,但与 CAD 的严重程度无关。